With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...

Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and welcome to the Vertex Inc. Third Quarter 2024 ...

Hello and thanks for joining us to discuss Vertex Inc third quarter financial results. I'm Joe Crivelli, Vice President, Investor Relations, David DiStefano, our President and CEO and John Schwab. Our ...

Vertex Minerals Ltd. (AU:VTX) has released an update. Vertex Minerals Ltd. is advancing the redevelopment of the Reward Gold Mine with the ...

Wait for the stock to set up and breakout from a new base and entry price. Also understand that the latest pattern is a later ...

Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a ...

Landers Superstore, the fastest-growing membership shopping store in the country, has clinched the coveted title of Retailer ...

On Monday, Vertex Inc (VERX) stock saw a decline, ending the day at $49.29 which represents a decrease of $-2.70 or -5.19% from the prior close of $51.99. The stock opened at $50.35 and touched a low ...

Vertex is approaching two key PDUFA dates in January for new treatments in cystic fibrosis and pain respectively.

VRTX to report Q3 earnings, expected EPS $4.14 and $2.72B in revenue. Cramer calls it a buy, analysts see 22% upside. Stock ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price raised by research analysts at Scotiabank from ...